Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer

Clinical trial NCT05620134 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05620134
Sponsor: Salubris Biotherapeutics Inc
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cancer Tumor, Solid Advanced Solid Tumor Metastatic Cancer Melanoma Colorectal Cancer Non-small Cell Lung Cancer Small-cell Lung Cancer Urothelial Carcinoma Squamous Cell Carcinoma of Head and Neck Luminal Breast Cancer Triple Negative Breast Cancer

Start date: 2022-10-17
Primary completion: 2025-10-17
Enrollment: 263

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.